Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher to Market Nanosphere Products in Certain European Countries

NEW YORK (GenomeWeb News) – Nanosphere today said that Thermo Fisher Scientific will market and distribute its Verigene products in Germany, Austria, and France.

Nanosphere recently received the CE Mark for its Verigene molecular diagnostics system and certain assays targeted at the microbiology market. Financial and other terms of the agreement were not disclosed.

"The agreement will focus on Verigene products that provide rapid identification of infectious diseases and associated drug resistance, arming physicians and hospitals with clinically actionable results that improve patient care and reduce the cost of treating critical illnesses," Paul James, Thermo Fisher's European vice president and general manager for microbiology, said in a statement.

Nanosphere said that it now has distribution agreements in place for all of the major markets in Europe.

The Verigene system was initially cleared for marketing in the US in 2007, and Nanosphere has US Food and Drug Administration clearance for several assays that run on the system. Most recently, it obtained 510(k) clearance for its Verigene Staphylococcus Blood Culture Nucleic Acid Test, or BC-S.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.